Skip to content
CompanySight
Company No. 10509764 · Incorporated 5 Dec 2016

Northumbria Pharma Ltd

Registered name: NORTHUMBRIA PHARMA LTD

Part of Northumbria Pharma Group Holdings Ltd group

Northumbria Pharma Ltd made £44.5m revenue and £10.6k profit in the year to 30 Apr 2025. read from filing text

Northumbria Pharma Ltd’s revenue grew 48% to £44.5m in the year to 30 Apr 2025, with £10.6k profit and 29 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Sedgefield; we hold 4 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 21200Manufacture of pharmaceutical preparations
Status
Active
Location
Sedgefield, North East
Age
9 yrs · since 2016
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The”

Latest accounts · year to 30 Apr 2025

Key figures

Capital-lightCash flow filed
Revenue
£44.5m
Growth ▲48.4%
Profit
£10.6k
Growth ▼90.8%
Profit margin
0%
Gross 5.8%
Employees
29
Change ▲3.6%
Profit / employee
£367
Revenue/employee £1.5m
Profitable streak
2yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to30 Apr 202230 Apr 202330 Apr 202430 Apr 2025
DisclosureNo P&LNo P&LFull P&Lread from filing textFull P&Lread from filing text
Profit & loss
Revenue (turnover)——£30m£44.5m
Cost of sales——£27.4m£41.9m
Gross profit——£2.5m£2.6m
Operating profit——£190k−£31.2k
Profit before tax——£157k−£29.5k
Profit after tax——£115k£10.6k
Profit (best available)——£115k£10.6k
Staff costs——£1.3m£1.5m
Employees (average)29232829
Ratios
Profit margin——0.4%0%
Gross margin——8.4%5.8%
Revenue per employee——£1.1m£1.5m
Profit per employee——£4.1k£367
Cash conversion——−298.8%—
Growth (year on year)
Revenue growth———▲48.4%
Profit growth———▼90.8%
Headcount growth—▼20.7%▲21.7%▲3.6%
Balance sheet — indirect signals, not revenue
Cash at bank£434k£906k£1.2m£5.3m
Net assets£1.5m£1.6m£1.7m£1.7m
Fixed assets£1.1m£1.5m£1.3m£1.2m
Current assets£2.5m£6.4m£4.7m£38.2m
Debtors£463k£2.1m£1.5m£19.4m
Deferred income£19.7k£337k£1.3m£1m
Cash from operations——−£568k−£4.4m
SourceFullAccounts · bulk data Apr 2024FullAccounts · bulk data Apr 2024FullAccounts · bulk data May 2025FullAccounts · bulk data Jan 2026
Derived from the latest filing

How the business works

Profit margin
0%
Profit ÷ revenue.
Gross margin
5.8%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£1.5m
Revenue ÷ average employees.
Profit per employee
£367
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
2.6%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
2.3%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
43.6%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲1%
Now £1.7m
Cash at bank
▲340%
Now £5.3m
Headcount
▲4%
Now 29
Deferred income
▼23%
Now £1m
Fixed assets
▼11%
Now £1.2m
Corporate ownership

Group structure

Ownership chain

  1. Northumbria Pharma Group Holdings Ltdultimate parent75–100%
  2. Northumbria Pharma Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (2)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 30 Apr 2025 (profit £10.6k), from the Companies House accounts bulk data published Jan 2026. Spotted an error? Request a correction.

Updated from Companies House on 15 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.